Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Daiichi Sankyo
Fuji
Teva
Cerilliant
US Department of Justice
Dow
Chubb
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

CUTIVATE Drug Profile

« Back to Dashboard

Which patents cover Cutivate, and when can generic versions of Cutivate launch?

Cutivate is a drug marketed by Fougera Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has seventeen patent family members in fifteen countries and four supplementary protection certificates in three countries.

The generic ingredient in CUTIVATE is fluticasone propionate. There are twenty-five drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fougera PharmsCUTIVATEfluticasone propionateCREAM;TOPICAL019958-001Dec 18, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Fougera PharmsCUTIVATEfluticasone propionateOINTMENT;TOPICAL019957-001Dec 14, 1990ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fougera PharmsCUTIVATEfluticasone propionateLOTION;TOPICAL021152-001Mar 31, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Fougera PharmsCUTIVATEfluticasone propionateLOTION;TOPICAL021152-001Mar 31, 2005ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CUTIVATE

Drugname Dosage Strength RLD Submissiondate
fluticasone propionateLotion0.05%Cutivate7/28/2008

International Patent Family for Tradename: CUTIVATE

Country Document Number Estimated Expiration
Turkey200101109► Subscribe
Poland348029► Subscribe
Czech Republic20011419► Subscribe
World Intellectual Property Organization (WIPO)0024401► Subscribe
Canada2347109► Subscribe
Australia754480► Subscribe
Hungary0104251► Subscribe
Australia6352499► Subscribe
China1326350► Subscribe
Japan2002528418► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CUTIVATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0014France► SubscribePRODUCT NAME: FLUTICASONE FLUORATE; REG. NO/DATE: EU/1/07/434/001 20080111
269Luxembourg► SubscribePRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
C/GB08/026United Kingdom► SubscribePRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080111; UK EU/1/07/434/002 20080111; UK EU/1/07/434/003 20080111
C0067France► SubscribePRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Harvard Business School
Mallinckrodt
Merck
Dow
Moodys
Cerilliant
Healthtrust
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot